PEGylated Cisplatin Nanoparticles for Treating Colorectal Cancer in a pH-Responsive Manner

Colorectal cancer (CRC) is a common malignant tumor, and its incidence ranks third and mortality rate ranks second in the world. Cisplatin cannot target CRC cells and has notable toxicity, which significantly limits its clinical application. The emerging PEGylated nanodrug delivery system can improv...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wei, Sun, Yongjun, Chen, Jian, Jiang, Zhibin, Yang, Jinbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410866/
https://www.ncbi.nlm.nih.gov/pubmed/36033392
http://dx.doi.org/10.1155/2022/8023915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9410866/
https://www.ncbi.nlm.nih.gov/pubmed/36033392
http://dx.doi.org/10.1155/2022/8023915

Ejemplares similares